Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Young-Sub Shin
Full-time employees:1197
City:Seoul
Address:2477, Nambusunhwan-ro
IPO:2005-09-29
CIK:
Website:
General Outlook
When we look at how much money they make before expenses, they keep 0.448% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.134%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.049%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.057% return, is a testament to JW Pharmaceutical Corporation's adeptness in optimizing resource deployment. JW Pharmaceutical Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.145%. Furthermore, the proficiency of JW Pharmaceutical Corporation in capital utilization is underscored by a remarkable 0.279% return on capital employed.
Stock Prices
JW Pharmaceutical Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $59200, while its low point bottomed out at $58800. This variance in figures offers investors a lucid insight into the roller-coaster ride that is JW Pharmaceutical Corporation's stock market.
Liquidity Ratios
Analyzing 001067.KS liquidity ratios reveals its financial health of the firm.
The current ratio of 131.77% gauges short-term asset coverage for liabilities.
The quick ratio (92.87%) assesses immediate liquidity, while the cash ratio (5.54%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
131.77%
Quick Ratio
92.87%
Cash Ratio
5.54%
Profitability Ratios
001067.KS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 7.26% underscores its earnings before tax deductions.
The effective tax rate stands at 30.21%, revealing its tax efficiency.
The net income per EBT, 68.14%, and the EBT per EBIT, 54.33%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 13.35%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
7.26%
Effective Tax Rate
30.21%
Net Income per EBT
68.14%
EBT per EBIT
54.33%
EBIT per Revenue
13.35%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.32, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
93
Days of Inventory Outstanding
94
Operating Cycle
178.43
Days of Payables Outstanding
65
Cash Conversion Cycle
113
Receivables Turnover
4.31
Payables Turnover
5.59
Inventory Turnover
3.89
Fixed Asset Turnover
4.81
Asset Turnover
1.16
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 3809.98, and free cash flow per share, 2124.29, depict cash generation on a per-share basis.
The cash per share value, 4058.31, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.12, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
3809.98
Free Cash Flow per Share
2124.29
Cash per Share
4058.31
Operating Cash Flow Sales Ratio
0.12
Free Cash Flow to Operating Cash Flow Ratio
0.56
Cash Flow Coverage Ratio
0.59
Short Term Coverage Ratio
0.74
Capital Expenditure Coverage Ratio
2.26
Dividend Paid and Capex Coverage Ratio
2.26
Dividend Payout Ratio
0.01
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 22.85%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.56, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 10.15%, and total debt to capitalization, 35.70%, ratios shed light on its capital structure.
An interest coverage of 10.39 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
22.85%
Debt Equity Ratio
0.56
Long Term Debt to Capitalization
10.15%
Total Debt to Capitalization
35.70%
Interest Coverage
10.39
Cash Flow to Debt Ratio
0.59
Company Equity Multiplier
2.43
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 32075.28, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 1585.77, reflects the portion of profit attributed to each share.
The book value per share, 11374.45, represents the net asset value distributed per share, while the tangible book value per share, 10073.64, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
32075.28
Net Income Per Share
1585.77
Book Value Per Share
11374.45
Tangible Book Value Per Share
10073.64
Shareholders Equity Per Share
11374.45
Interest Debt Per Share
6854.75
Capex Per Share
-1841.20
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 9.38%, indicates top-line expansion, while the gross profit growth, 16.57%, reveals profitability trends.
EBIT growth, 53.68%, and operating income growth, 53.68%, offer insights into operational profitability progression.
The net income growth, 16.04%, showcases bottom-line expansion, and the EPS growth, 18.69%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
9.38%
Gross Profit Growth
16.57%
EBIT Growth
53.68%
Operating Income Growth
53.68%
Net Income Growth
16.04%
EPS Growth
18.69%
EPS Diluted Growth
18.69%
Weighted Average Shares Growth
-2.45%
Weighted Average Shares Diluted Growth
-2.45%
Dividends per Share Growth
22.89%
Operating Cash Flow Growth
53.54%
Free Cash Flow Growth
-0.50%
10-Year Revenue Growth per Share
40.90%
5-Year Revenue Growth per Share
61.15%
3-Year Revenue Growth per Share
36.08%
10-Year Operating CF Growth per Share
245.38%
5-Year Operating CF Growth per Share
93.43%
3-Year Operating CF Growth per Share
37.54%
10-Year Net Income Growth per Share
1107.04%
5-Year Net Income Growth per Share
431.19%
3-Year Net Income Growth per Share
341.05%
10-Year Shareholders Equity Growth per Share
-1.88%
5-Year Shareholders Equity Growth per Share
18.02%
3-Year Shareholders Equity Growth per Share
27.29%
10-Year Dividend per Share Growth per Share
351.15%
3-Year Dividend per Share Growth per Share
26.11%
Receivables Growth
7.08%
Inventory Growth
-4.99%
Asset Growth
2.72%
Book Value per Share Growth
13.21%
Debt Growth
-18.74%
R&D Expense Growth
-0.19%
SGA Expenses Growth
61.94%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,605,905,478,961, captures the company's total value, considering both debt and equity.
Income quality, 2.48, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.16, gauges operational efficiency, while the research and development to revenue, 4.50%, highlights investment in innovation.
The ratio of intangibles to total assets, 4.71%, indicates the value of non-physical assets, and capex to operating cash flow, -49.30%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
1,605,905,478,961
Income Quality
2.48
Sales General and Administrative to Revenue
0.16
Research and Development to Revenue
4.50%
Intangibles to Total Assets
4.71%
Capex to Operating Cash Flow
-49.30%
Capex to Revenue
-5.74%
Capex to Depreciation
-191.44%
Graham Number
20145.41
Return on Tangible Assets
6.02%
Graham Net Net
-4434.79
Working Capital
91,164,236,688
Tangible Asset Value
235,084,032,801
Net Current Asset Value
-1,506,988,918
Invested Capital
1
Average Receivables
167,887,746,182.5
Average Payables
78,377,546,500
Average Inventory
108,879,890,634
Days Sales Outstanding
85
Days Payables Outstanding
65
Days of Inventory On Hand
94
ROIC
16.35%
ROE
0.14%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.11, and the price to book ratio, 5.11, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 0.95, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 14.56, and price to operating cash flows, 15.56, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
5.11
Price to Book Ratio
5.11
Price to Sales Ratio
0.95
Price Cash Flow Ratio
15.56
Price Earnings to Growth Ratio
0.93
Enterprise Value Multiple
1.98
Price Fair Value
5.11
Price to Operating Cash Flow Ratio
15.56
Price to Free Cash Flows Ratio
14.56
Price to Tangible Book Ratio
5.47
Enterprise Value to Sales
2.15
Enterprise Value Over EBITDA
13.47
EV to Operating Cash Flow
18.43
Earnings Yield
2.55%
Free Cash Flow Yield
3.04%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
